Invest in Anestagel. A new, opioid-free painkiller.
Why We Created Anestagel.
Anestagel™ Accepting Accredited investors now.
Anestagel Medical Specialties.
InSitu Biologics- Anestagel™- Eliminate the need for addictive opiates
for pain management after surgery.
Anestagel is aiming to be in their repertoire of opioid alternatives
as this change, which will take decades, begins.
Our patent position and refinement of product components represent years of research and development being captured to bring Anestagel to the market.
Anestagel is a pre-clinical phase pain relief
drug that consists of bupivicaine, a surgical strength“caine” medication like novacaine or lidocaine, that is released over 72-96 hours via our Matrix BioHydrogel.
Anestagel is placed on the tissue at the surgical site,
and only the drug that is in the Matrix BioHydrogel works its way in to the bloodstream to relieve pain.
While complex in its design, and intricate to make, we believe Anestagel represents that rare case for a potentially large return on investment,
due to our low market capitalization in a large cap market.